Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase-1 and -2.
Clarke MR, Imhoff FM, Baird SK. Clarke MR, et al. Among authors: imhoff fm. Mol Carcinog. 2015 Oct;54(10):1214-9. doi: 10.1002/mc.22178. Epub 2014 May 13. Mol Carcinog. 2015. PMID: 24819588
Mesenchymal stem cell homing towards cancer cells is increased by enzyme activity of cathepsin D.
Vangala G, Imhoff FM, Squires CML, Cridge AG, Baird SK. Vangala G, et al. Among authors: imhoff fm. Exp Cell Res. 2019 Oct 1;383(1):111494. doi: 10.1016/j.yexcr.2019.07.007. Epub 2019 Jul 12. Exp Cell Res. 2019. PMID: 31306655
The type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitors.
Imhoff FM, Yang D, Mathew SF, Clarkson AN, Kawagishi Y, Tate WP, Koishi K, McLennan IS. Imhoff FM, et al. FEBS Lett. 2013 Jun 19;587(12):1749-53. doi: 10.1016/j.febslet.2013.04.014. Epub 2013 Apr 25. FEBS Lett. 2013. PMID: 23624077 Free article.
Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior.
Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K, McLennan IS. Wang PY, et al. Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7203-8. doi: 10.1073/pnas.0902253106. Epub 2009 Apr 9. Proc Natl Acad Sci U S A. 2009. PMID: 19359476 Free PMC article.
Feedback